Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease - Not Only Premature But Also Confusing.
作者信息
Duseja Ajay, Taneja Sunil
机构信息
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
出版信息
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):278-279. doi: 10.1016/j.jceh.2020.08.002. Epub 2020 Aug 9.
Abstract
摘要
相似文献
1
Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease - Not Only Premature But Also Confusing.将非酒精性脂肪性肝病的命名改为代谢功能障碍相关脂肪性肝病——不仅为时过早，而且令人困惑。
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):278-279. doi: 10.1016/j.jceh.2020.08.002. Epub 2020 Aug 9.
2
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?从非酒精性脂肪性肝病（NAFLD）到代谢功能障碍相关脂肪性肝病（MAFLD）——儿科患者的新术语，是朝着良好科学方向迈出的一步吗？
J Clin Med. 2021 Mar 1;10(5):924. doi: 10.3390/jcm10050924.
3
Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.评论：非酒精性或代谢功能障碍相关脂肪性肝病？寻找最合适名称的21世纪流行病。
Metabolism. 2020 Dec;113:154413. doi: 10.1016/j.metabol.2020.154413. Epub 2020 Oct 22.
4
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
5
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.评估水飞蓟宾联合维生素 D 和维生素 E 治疗对非酒精性脂肪性肝病患者临床、代谢、内皮功能障碍、氧化应激参数和血清恶化标志物的影响。
Oxid Med Cell Longev. 2019 Oct 15;2019:8742075. doi: 10.1155/2019/8742075. eCollection 2019.
6
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.非酒精性脂肪性肝病与心血管疾病表型
SAGE Open Med. 2020 Jun 20;8:2050312120933804. doi: 10.1177/2050312120933804. eCollection 2020.
7
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?非酒精性脂肪性肝病（NAFLD）名称变更：挽歌还是警钟？
J Clin Transl Hepatol. 2021 Dec 28;9(6):931-938. doi: 10.14218/JCTH.2021.00174. Epub 2021 Aug 24.
8
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.非酒精性脂肪性肝病是代谢健康人群代谢性疾病的早期预测指标。
PLoS One. 2019 Nov 4;14(11):e0224626. doi: 10.1371/journal.pone.0224626. eCollection 2019.
9
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.非酒精性脂肪性肝病：代谢综合征的前驱病变
Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.
10
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.非肥胖非糖尿病土耳其人群中胰岛素抵抗、代谢综合征与非酒精性脂肪性肝病之间的关系：一项初步研究。
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.
引用本文的文献
1
MASLD, MLA Pesarattu and Other Developments.代谢功能障碍相关脂肪性肝病、MLA佩萨拉图及其他进展
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102465. doi: 10.1016/j.jceh.2024.102465. Epub 2024 Nov 22.
2
Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?非酒精性脂肪性肝病与代谢相关脂肪性肝病与代谢功能障碍相关脂肪性肝病：名称里有什么含义？
Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):1-4. doi: 10.5005/jp-journals-10018-1424.
3
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.饮酒与代谢相关脂肪性肝病（MAFLD）对进展性脂肪性肝病的双向影响。
Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.
4
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLD.关于非酒精性脂肪性肝病更名为代谢相关脂肪性肝病的国际非酒精性脂肪性肝病研究学会-亚太地区非酒精性脂肪性肝病研究学会共识声明
J Clin Exp Hepatol. 2023 May-Jun;13(3):518-522. doi: 10.1016/j.jceh.2022.12.011. Epub 2023 Jan 20.
5
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会（INASL）关于非酒精性脂肪性肝病（NAFLD）命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
6
The NAFLD-MAFLD debate through the lens of the Arab world.从阿拉伯世界的视角看非酒精性脂肪性肝病与代谢相关性脂肪性肝病之争。
Saudi J Gastroenterol. 2022 Nov-Dec;28(6):413-416. doi: 10.4103/sjg.sjg_314_22.
本文引用的文献
1
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病：术语过早改变的影响。
Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.
2
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
3
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
4
High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India.印度城市健康男性献血者中非酒精性脂肪性肝病的高患病率。
JGH Open. 2019 Jan 16;3(2):133-139. doi: 10.1002/jgh3.12117. eCollection 2019 Apr.
5
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.2017年亚太地区非酒精性脂肪性肝病工作小组指南 - 第1部分：定义、危险因素及评估
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.
6
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.非酒精性脂肪性肝病与代谢综合征——印度国家肝脏研究协会、印度内分泌学会、印度心脏病学会和印度胃肠病学会的立场文件
J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6.
7
Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.在一个发展中国家，非酒精性脂肪肝是导致严重肝脏疾病的原因。
Hepatology. 2010 Dec;52(6):2248-9. doi: 10.1002/hep.23838. Epub 2010 Jul 29.
8
Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.发展中国家的非肥胖人群中非酒精性脂肪肝和显著肝脏疾病的患病率很高。
Hepatology. 2010 May;51(5):1593-602. doi: 10.1002/hep.23567.
Zotero 插件